1. Home
  2. IXHL vs ACCL Comparison

IXHL vs ACCL Comparison

Compare IXHL & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$1.96

Market Cap

35.4M

Sector

N/A

ML Signal

N/A

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$2.38

Market Cap

36.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
IXHL
ACCL
Founded
2001
2009
Country
Australia
Hong Kong
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
35.4M
36.3M
IPO Year
2024
2024

Fundamental Metrics

Financial Performance
Metric
IXHL
ACCL
Price
$1.96
$2.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 69.0K
2.4K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $12,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$17.13
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$1.23
52 Week High
$6.39
$4.98

Technical Indicators

Market Signals
Indicator
IXHL
ACCL
Relative Strength Index (RSI) 21.19 40.17
Support Level $0.20 $1.32
Resistance Level $3.82 $2.89
Average True Range (ATR) 0.19 0.09
MACD -0.04 -0.02
Stochastic Oscillator 6.02 18.33

Price Performance

Historical Comparison
IXHL
ACCL

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: